SCHEMBL14420184

SCHEMBL14420184

COc1ccc2c(c1)C(=CCCN1CCC(N=[N+]=[N-])(c3ccc(Cl)cc3)CC1)c1cccnc1CO2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 2/20 0.56
▸ CHRM2 P08172 1/20 0.47
▸ CCR5 P51681 1/20 0.47
▸ TBXA2R P21731 2/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ HRH1 P35367 4/20 0.31
▸ ADRA1D P25100 1/20 0.31
▸ ADRA1A P35348 1/20 0.31
▸ ADRA1B P35368 1/20 0.31
▸ XBP1 P17861 1/20 0.30
▸ HSPA9 P38646 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ ALOX12 P18054 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13617505 0.89 CCR1 (0.57) CCR1CHRM2CCR5TBXA2RLMNA
SCHEMBL7210849 0.88 CCR1 (0.63) CCR1CHRM2CCR5NPC1ALDH1A1
SCHEMBL7210846 0.88 CCR1 (0.63) CCR1CHRM2CCR5NPC1ALDH1A1
SCHEMBL15478347 0.87 CCR1 (0.51) CCR1CHRM2CCR5TBXA2RNPC1
SCHEMBL10287606 0.85 CCR1 (0.52) CCR1CHRM2CCR5TBXA2RNPC1
SCHEMBL14419991 0.85 CCR1 (0.58) CCR1CHRM2CCR5TBXA2RHRH1
SCHEMBL13824476 0.85 CCR1 (0.58) CCR1CHRM2CCR5TBXA2RHRH1
SCHEMBL12121524 0.85 CCR1 (0.60) CCR1CHRM2CCR5NPC1ALDH1A1
SCHEMBL14419988 0.85 CCR1 (0.65) CCR1CHRM2CCR5TBXA2RNPC1
SCHEMBL10287614 0.84 CCR1 (0.57) CCR1CHRM2CCR5TBXA2RHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7271176-B2 Chemokine receptor antagonists and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2007-09-18 — — US disclosed
Send feedback